Answers are grounded in this paper and cite their sources.
Background Patients with sarcoidosis may demonstrate different pulmonary function test (PFT) patterns, including obstructive and restrictive dysfunction; however, data regarding the clinical significance of these patterns remain limited. This study aimed to compare the clinical features and laboratory characteristics of patients with sarcoidosis according to PFT patterns. Methods This multicenter retrospective observational study included 590 patients diagnosed with sarcoidosis in 9 referral centers of our country between January 2015 and April 2023. Patients were classified into normal, obstructive, and restrictive PFT pattern groups according to spirometry. Demographic characteristics, laboratory parameters, radiological stages, and DLCO values at the time of diagnosis, treatment status, and recurrence rates during 2-year follow-up were compared among the PFT groups. Univariable and multivariable logistic regression analyses were performed to identify factors independently associated with PFT patterns. Results There was 590 patients and mean age was 49.2, and 69% of them was female. Of the all patients, 359 (60.9%) had normal PFT findings, 139 (23.6%) had obstructive patterns, and 92 (15.6%) had restrictive patterns. Obstructive dysfunction was more common than restrictive dysfunction. Compared with the normal and obstructive groups, patients with restrictive PFT patterns had significantly more advanced radiological stages, lower DLCO values, and higher rates of systemic immunosuppressive treatment. Patients with restrictive patterns were also older and more frequently symptomatic than those with normal PFT findings. In multivariable logistic regression analysis, lower DLCO% values remained independently associated with restrictive PFT patterns both compared with normal PFT patterns (AOR: 0.90, 95% CI: 0.87–0.92) and obstructive PFT patterns (AOR: 0.92, 95% CI: 0.89–0.94). Conclusions Patients presenting with restrictive dysfunction at diagnosis may require closer clinical monitoring and follow-up owing to their potentially more severe disease course.
No takes yet. Share an insight, caveat, or question.
Eroğlu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: